Johnson & Johnson: all 3,718 studies

Page 15 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate Usage of Mineral Sunscreens With Differentiated Whitening Attributes in Multi-Cultural Skin TonesCompletedNCT06734299Not applicable
• A Non-Treatment Clinical Evaluation of the ELITA Single Piece Patient Interface for Docking Procedure With the ELITACompletedNCT06727799
• Safety and Performance of the OTTAVA Robotic SystemCompletedNCT06709261Not applicable
• A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open SurgeryActive, not recruitingNCT06664788Not applicable
• A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)Active, not recruitingNCT06660563Phase 1
• A Study to Evaluate the Effect of a Topical Retinol on Epigenetic Changes and Expression of Certain Genes in the Skin Using Non-invasive MeasurementsCompletedNCT06658847Not applicable
• A Study to Evaluate the Cutaneous Effects of Deep Ultraviolet A +/- High-Energy Visible Blue Light ExposureCompletedNCT06654102Not applicable
• A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic NeoplasmsActive, not recruitingNCT06651229Phase 1
• Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT06627413Phase 1
• A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic NeoplasmsActive, not recruitingNCT06618001Phase 1
• A Study of HARMONIC 700 Shears With Advanced Hemostasis in Pediatric and Adult Surgical ProceduresCompletedNCT06608485
• A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT06604715Phase 1
• A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple MyelomaActive, not recruitingNCT06577025Phase 2
• Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum DisorderCompletedNCT06557902Phase 1
• A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple MyelomaActive, not recruitingNCT06550895Phase 2
• A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's DiseaseActive, not recruitingNCT06544616Phase 2
• A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung CancerCompletedNCT06532032Phase 1/2
• A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With AticaprantTerminatedNCT06514742Phase 3
• Exploratory Safety and Effectiveness Evaluation of Pulsed Field Ablation (PFA) by Balloon Catheter With TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF)WithdrawnNCT06495216Not applicable
• Four-Week Oral Malodor and Clinical Safety for a Concentrated Cosmetic MouthwashCompletedNCT06479096Not applicable
• A Real-world Study in Participants With Smoldering Multiple MyelomaCompletedNCT06472778
• A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's LymphomaActive, not recruitingNCT06470438Phase 1
• Study of Lumateperone in the Treatment of Patients With Bipolar ManiaCompletedNCT06462612Phase 3
• Study of Lumateperone in the Acute Treatment of Patients With Bipolar ManiaCompletedNCT06462586Phase 3
• A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)Active, not recruitingNCT06455098Not applicable
• A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT06425991Phase 1
• Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease PatientsActive, not recruitingNCT06408935Phase 3
• Safety, Performance of CEREGLIDE 92 Intermediate Catheter in Treatment of Acute Ischemic StrokeWithdrawnNCT06386289Not applicable
• Evaluation of the Acceptability and Feasibility of a Bedtime Routine for NeonatesCompletedNCT06318637Not applicable
• PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy SubjectsCompletedNCT06299410Phase 1
• A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAFOUSCompletedNCT06272981Not applicable
• A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT06260163Phase 3
• A Study of JNJ-79032421 Targeting Mesothelin for Advanced Stage Solid TumorsCompletedNCT06255665Phase 1
• A Multicenter, Observational, Single Arm Study of the TECNIS Presbyopia-correcting Intraocular LensCompletedNCT06250322
• A Study to Assess Safety and Improvement in Skin Barrier After Using 2 Facial Sunscreens in Adults With Sensitive SkinCompletedNCT06243627Not applicable
• A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)Active, not recruitingNCT06211764Phase 3
• Clinical Investigation on Assessing the Repeatability and Reproducibility of Central and Peripheral Refractive ErrorCompletedNCT06209476
• A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and LenalidomideActive, not recruitingNCT06208150Phase 3
• A Study of Sterile Saline Infusion in Healthy VolunteersCompletedNCT06194578Early Phase 1
• A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAFCompletedNCT06144632Not applicable
• A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) CancerActive, not recruitingNCT06139406Phase 1
• A Study to Investigate Salivary Flow and Potential of Hydrogen (pH) Following Use of Essential-Oil Containing MouthwashesCompletedNCT06136455Phase 4
• Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus LazertinibActive, not recruitingNCT06120140Phase 2
• A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung CancerActive, not recruitingNCT06116786Phase 1
• Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple SclerosisCompletedNCT06083753Phase 2
• A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in ChinaCompletedNCT06082986
• Characterization of the Central and Peripheral Wavefront Aberration Profile in Pediatric Myopic SubjectsCompletedNCT06075576
• A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) PopulationCompletedNCT06052319
• A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT06049017Phase 2
• A Two-Week Study of an Anticavity Low pH MouthwashCompletedNCT06010758Phase 4
• User Acceptability Evaluation of Pseudophakic Patients Previously Implanted With the TECNIS Odyssey IOLCompletedNCT06005675
• Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOLCompletedNCT05991960
• A Study of Two Facial Sunscreens to Assess Its Effect in Improving Hydration, Skin Barrier Function, and Skin Tone Uniformity Under Controlled and Normal Conditions of Use on the Face by Adult ParticipantsCompletedNCT05972434Not applicable
• A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic LeukemiaActive, not recruitingNCT05963074Phase 2
• Global Patient Registry of Inherited Retinal DiseasesCompletedNCT05957276
• A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung CancerActive, not recruitingNCT05908734Phase 1/2
• A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or EnzalutamideCompletedNCT05901649
• A Study of Lazertinib (JNJ-73841937) Tablet in Healthy Adult ParticipantsCompletedNCT05896683Phase 1
• A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPCActive, not recruitingNCT05884398Phase 3
• A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin ChallengeCompletedNCT05884242Phase 1
• DISRUPT PAD III Observational StudyCompletedNCT05881421
• A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following BunionectomyCompletedNCT05868122Phase 3
• A Study to Assess Effect of Two Facial Sunscreens in Improving Wrinkles, Fine Lines and Melasma in Adult ParticipantsCompletedNCT05864417Not applicable
• Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)TerminatedNCT05859724Phase 1
• A Multiple-Dose Safety Study of Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents With Orthodontic PainWithdrawnNCT05845008Phase 3
• A Study of Acetaminophen/Naproxen Sodium Fixed Combination Tablets in Adolescents 12 to <17 Years of Age With PainCompletedNCT05844995Phase 1
• A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)CompletedNCT05841030
• A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy ParticipantsCompletedNCT05827874Phase 1
• Impella Real-World Surveillance of Patients Using Sodium BicarbonateCompletedNCT05820451
• A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)CompletedNCT05811351Phase 2
• A Study of a Whole-Body Balm on Newborn BabiesCompletedNCT05786209Not applicable
• A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)Active, not recruitingNCT05784441Phase 1
• Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's DiseaseCompletedNCT05766813Phase 2
• A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental PainCompletedNCT05761574Phase 3
• V-A ECMO AUTO Mode RegistryCompletedNCT05759377
• Pre-Approval Access Program for Talquetamab in Relapsed or Refractory Multiple MyelomaApproved for marketingNCT05757973
• A Study of Milvexian Versus Apixaban in Participants With Atrial FibrillationActive, not recruitingNCT05757869Phase 3
• IMPACT EU Post-Market Clinical Follow-Up StudyActive, not recruitingNCT05756751Not applicable
• A Study of Virtually Supervised Mouthwash and Interdental BrushesCompletedNCT05756673Phase 4
• A Study of Milvexian in Participants After a Recent Acute Coronary SyndromeCompletedNCT05754957Phase 3
• A Study of Four Different Oral Tablet Formulations of Lazertinib (JNJ-73841937) in Healthy Adult ParticipantsCompletedNCT05742594Phase 1
• A Study of Macitentan in Children Below 2 Years of AgeWithdrawnNCT05731492Phase 1
• A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)Active, not recruitingNCT05714202Phase 3
• A PHASED, PROSPECTIVE, MULTI-CENTER STUDY OF THE ELITA SYSTEMTerminatedNCT05713253Not applicable
• A Study of Milvexian in Healthy Adult FemalesCompletedNCT05706753Phase 1
• A Study of JNJ-77242113 Following Oral Administration in Healthy Chinese Adult ParticipantsCompletedNCT05703841Phase 1
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKEActive, not recruitingNCT05702034Phase 3
• A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe IllnessCompletedNCT05661604
• A Two-Week Study of Clinical Safety and Saliva Flow QuantificationCompletedNCT05645705Phase 4
• Evaluating ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia ManagementCompletedNCT05634408Not applicable
• Characterizing the Intraocular Scattering at Different WavelengthsCompletedNCT05602623Not applicable
• A Study of Virtually Supervised Mouth Rinses and FlossingCompletedNCT05600231Phase 4
• A Study of a Baby Wash/Shampoo and Baby Lotion Versus Baby Wash/Shampoo Alone for Impact on Skin Barrier and Microbiome on NewbornsTerminatedNCT05589038Not applicable
• A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT05572515Phase 3
• A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder CancerActive, not recruitingNCT05567185Phase 1
• A Study to Evaluate the Whitening Effect of Mineral Sunscreens in Multi-Cultural Skin TonesCompletedNCT05565625Not applicable
• A Study of Ponesimod in Healthy Adult ParticipantsCompletedNCT05552196Phase 1
• A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) TreatmentWithdrawnNCT05550519Early Phase 1
• A Single Ascending Dose Study of JNJ-88260237 in Healthy ParticipantsCompletedNCT05541315Phase 1
• PROOF-OF-CONCEPT STUDY FOR NEW INTRAOCULAR LENS, MODEL C0002CompletedNCT05531292Not applicable

← Johnson & Johnson overview and focus areas